Deltec Asset Management’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-999
Closed -$192K 192
2019
Q3
$192K Sell
999
-916
-48% -$176K 0.05% 151
2019
Q2
$328K Buy
1,915
+384
+25% +$65.8K 0.07% 139
2019
Q1
$308K Hold
1,531
0.07% 134
2018
Q4
$287K Sell
1,531
-2,073
-58% -$389K 0.08% 124
2018
Q3
$862K Sell
3,604
-2,467
-41% -$590K 0.17% 103
2018
Q2
$1.61M Buy
+6,071
New +$1.61M 0.32% 67